These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 22341574

  • 1. Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis.
    Arns S, Gibe R, Moreau A, Monzur Morshed M, Young RN.
    Bioorg Med Chem; 2012 Mar 15; 20(6):2131-40. PubMed ID: 22341574
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosis.
    Vachal P, Hale JJ, Lu Z, Streckfuss EC, Mills SG, MacCoss M, Yin DH, Algayer K, Manser K, Kesisoglou F, Ghosh S, Alani LL.
    J Med Chem; 2006 Jun 01; 49(11):3060-3. PubMed ID: 16722624
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and in vivo bioactivity of lipophilic alendronate derivatives against osteoporosis.
    Lu TL, Hu HJ, Zhao W, Chen T.
    Drug Dev Ind Pharm; 2011 Jun 01; 37(6):656-63. PubMed ID: 21449707
    [Abstract] [Full Text] [Related]

  • 7. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA, Damron TA, Horton JA, Margulies BS, Murray GM, Clemente DA, Strauss JA.
    J Orthop Res; 2006 May 01; 24(5):936-44. PubMed ID: 16609966
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.
    Kambe T, Maruyama T, Nakai Y, Yoshida H, Oida H, Maruyama T, Abe N, Nishiura A, Nakai H, Toda M.
    Bioorg Med Chem; 2012 Apr 01; 20(7):2235-51. PubMed ID: 22386979
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.
    Bagi CM, Volberg M, Moalli M, Shen V, Olson E, Hanson N, Berryman E, Andresen CJ.
    Anat Rec (Hoboken); 2007 Aug 01; 290(8):1005-16. PubMed ID: 17610276
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drug injury in the upper gastrointestinal tract: effects of alendronate.
    Khapra AP, Rose S.
    Gastrointest Endosc Clin N Am; 2006 Jan 01; 16(1):99-110. PubMed ID: 16546026
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
    Fuchs RK, Shea M, Durski SL, Winters-Stone KM, Widrick J, Snow CM.
    Bone; 2007 Aug 01; 41(2):290-6. PubMed ID: 17544352
    [Abstract] [Full Text] [Related]

  • 18. [Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
    Yamada S, Inaba M, Nishizawa Y.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():348-51. PubMed ID: 18161129
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.